LEG (Leggett & Platt, Inc.) Stock Analysis - News

Leggett & Platt, Inc. (LEG) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, LEG trades at $9.44 with a market cap of $1.27B and a P/E ratio of 5.97. LEG moved +5.63% today. Year to date, LEG is -11.49%; over the trailing twelve months it is +6.65%. Its 52-week range spans $6.48 to $14.24. Analyst consensus is neutral with an average price target of $11.50. Rallies surfaces LEG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in LEG news today?

Leggett & Platt Q1 Sales Drop 10% to $918M, EPS Slides to $0.15: Leggett & Platt posted Q1 sales of $918 million, down 10% year-over-year including a 5% reduction from divestitures, with adjusted EPS of $0.15, a $0.09 decline. The company withdrew its 2026 guidance ahead of a pending Somnigroup acquisition, citing weak mattress demand and rising costs.

LEG Key Metrics

Key financial metrics for LEG
MetricValue
Price$9.44
Market Cap$1.27B
P/E Ratio5.97
EPS$1.62
Dividend Yield0.05%
52-Week High$14.24
52-Week Low$6.48
Volume2
Avg Volume0
Revenue (TTM)$3.95B
Net Income$224.80M
Gross Margin18.34%

Latest LEG News

LEG Analyst Consensus

3 analysts cover LEG: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $11.50.

Common questions about LEG

What changed in LEG news today?
Leggett & Platt Q1 Sales Drop 10% to $918M, EPS Slides to $0.15: Leggett & Platt posted Q1 sales of $918 million, down 10% year-over-year including a 5% reduction from divestitures, with adjusted EPS of $0.15, a $0.09 decline. The company withdrew its 2026 guidance ahead of a pending Somnigroup acquisition, citing weak mattress demand and rising costs.
Does Rallies summarize LEG news?
Yes. Rallies summarizes LEG news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is LEG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LEG. It does not provide personalized investment advice.
LEG

LEG